Related Articles
Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors
High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer
Microtubule alterations and resistance to tubulin-binding agents (Review)
Prognostic significance of the mRNA expression of ERCC1, RRM1, TUBB3 and TYMS genes in patients with non-small cell lung cancer
High expression levels of class III β‑tubulin in resected non‑small cell lung cancer patients are predictive of improved patient survival after vinorelbine‑based adjuvant chemotherapy